Sumitomo Chemical India Limited SUMICHEM NIFTY_SMALLNSEINFRA
Basic Materials · Agricultural Inputs · India
Sumitomo Chemical India Limited engages in the manufacture and sale of household and public health insecticides, agricultural pesticides, and animal nutrition products in India and internationally. It also offers crop protection products, such as insecticides, herbicides, fungicides, and miticides; animal nutrition; plant nutrition and plant growth regulators; fumigants and rodenticides; weedicides; and biological products. The company was incorporated in 2000 and is headquartered in Mumbai, India. Sumitomo Chemical India Limited is a subsidiary of Sumitomo Chemical Company Limited.
READ MORE ›₹501.55
-0.06% 1Y
Market & Price
Market Cap
₹25,034.65 Cr
Current Price
₹501.55
High / Low (52W)
₹652.25 / ₹364.45
Beta
-
Valuation
Stock P/E
46.10
Industry PE
23.81
Forward P/E
33.96
PEG Ratio
-
Book Value
₹64.03
Price to Book
7.83
P/S
7.40
EV/EBITDA
29.03
Dividend Yield
0.24%
Profitability & Returns
ROCE
20.98%
ROE
17.24%
ROA
11.13%
Profit Margin
16.04%
Op Margin
17.15%
EPS (Latest Qtr)
₹2.23
EPS (TTM)
₹10.88
Balance Sheet & Liquidity
Debt/Equity
1.86
Quick Ratio
1.80
Current Ratio
3.44
Debt
₹63.30 Cr
Total Assets
₹4,474.19 Cr
Current Assets
₹3,340.15 Cr
Working Capital
₹2,370.34 Cr
Ownership
Promoter Holding
75.48%
Chg in Prom Hold
-
FII / Inst Holding
8.80%
Chg in FII Hold
-
Financial Snapshot
Enterprise Value
₹23,732.92 Cr
Total Revenue (TTM)
₹3,385.04 Cr
EBITDA
₹817.59 Cr
Free Cash Flow
₹-85.53 Cr
Operating Cash Flow
₹445.51 Cr
Shares Outstanding
₹49.91 Cr
Gross Margin
44.54%
Payout Ratio
11.03%
Growth (CAGR)
Revenue 5Y
-2.31%
Profit 5Y
2.64%
Revenue (YoY)
0.60%
Earnings (YoY)
11.50%
PROS
- Healthy ROCE of 21.0%.
CONS
- Revenue declined at -2.3% CAGR over 5 years.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Peer comparison
Peer companies in the same sector (Basic Materials).
| # | Name | CMP ₹ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | SUMICHEM Sumitomo Chemical India Limited NIFTY_SMALLNSEINFRA | 501.55 | 46.10 | ₹25,034.65 Cr | 0.24% | 20.98% | 17.24% | -2.31% | 2.64% |
| 2 | ULTRACEMCO UltraTech Cement Limited NIFTY50NSEINFRA | 11,482.00 | 41.32 | ₹3.38 L Cr | 0.67% | 11.90% | 10.59% | 12.40% | 17.26% |
| 3 | JSWSTEEL JSW Steel Limited NIFTY50NSEAIINFRA | 1,278.00 | 14.01 | ₹3.12 L Cr | 0.56% | 19.15% | 27.26% | 3.61% | 75.28% |
| 4 | HINDZINC Hindustan Zinc Limited NSEINFRA | 632.95 | 19.34 | ₹2.67 L Cr | 3.32% | 62.35% | 76.94% | 5.61% | 9.58% |
| 5 | TATASTEEL Tata Steel Limited NIFTY50NSEAIINFRA | 208.02 | 28.34 | ₹2.59 L Cr | 1.92% | 11.32% | 11.16% | -1.59% | 7.21% |
| 6 | HINDALCO Hindalco Industries Limited NIFTY50NSEAIINFRA | 1,126.70 | 18.73 | ₹2.52 L Cr | 0.44% | 9.50% | 10.29% | 7.40% | 9.87% |
| 7 | GRASIM Grasim Industries Limited NIFTY50NSEINFRA | 3,122.40 | 42.74 | ₹2.12 L Cr | 0.32% | 4.00% | 6.29% | 14.63% | -10.06% |
| 8 | SOLARINDS Solar Industries India Limited NSEINFRA | 18,247.00 | 98.04 | ₹1.65 L Cr | 0.06% | 29.51% | 31.33% | 13.27% | 30.36% |
| 9 | PIDILITIND Pidilite Industries Limited NSEINFRA | 1,482.80 | 61.73 | ₹1.51 L Cr | 0.67% | 28.48% | 23.52% | 7.50% | 24.36% |
Ad space
Quarterly Results
Figures in INR.
| Metric | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | 988.30 Cr | 641.92 Cr | 679.42 Cr | 1,056.78 Cr | 567.98 Cr | 683.74 Cr |
| Cost of Revenue | 567.63 Cr | 371.38 Cr | 407.46 Cr | 654.41 Cr | 298.95 Cr | 394.80 Cr |
| Gross Profit | 420.67 Cr | 270.54 Cr | 271.96 Cr | 402.37 Cr | 269.03 Cr | 288.94 Cr |
| Operating Expenses | 191.11 Cr | 183.49 Cr | 168.81 Cr | 198.90 Cr | 186.28 Cr | 171.69 Cr |
| Operating Income | 229.56 Cr | 87.05 Cr | 103.15 Cr | 203.47 Cr | 82.75 Cr | 117.25 Cr |
| EBITDA | 276.51 Cr | 137.35 Cr | 151.18 Cr | 257.97 Cr | 120.33 Cr | 166.37 Cr |
| Interest Expense | 1.22 Cr | 1.79 Cr | 1.66 Cr | 1.66 Cr | 2.02 Cr | 1.91 Cr |
| Pretax Income | 259.57 Cr | 116.50 Cr | 133.11 Cr | 240.59 Cr | 101.57 Cr | 147.55 Cr |
| Tax Provision | 67.03 Cr | 29.07 Cr | 33.32 Cr | 62.50 Cr | 25.77 Cr | 36.23 Cr |
| Net Income | 192.29 Cr | 86.95 Cr | 99.58 Cr | 178.34 Cr | 75.63 Cr | 111.23 Cr |
| Diluted EPS | 3.85 | 1.74 | 2.00 | 3.57 | 1.52 | 2.23 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | - | 3,473.34 Cr | 2,817.77 Cr | 3,148.52 Cr | 3,238.32 Cr |
| Cost of Revenue | - | 2,285.49 Cr | 1,798.61 Cr | 1,858.92 Cr | 1,877.40 Cr |
| Gross Profit | - | 1,187.86 Cr | 1,019.16 Cr | 1,289.60 Cr | 1,360.91 Cr |
| Operating Expenses | - | 572.06 Cr | 591.69 Cr | 723.61 Cr | 756.17 Cr |
| Operating Income | - | 615.79 Cr | 427.47 Cr | 566.00 Cr | 604.74 Cr |
| EBITDA | - | 709.91 Cr | 568.73 Cr | 752.15 Cr | 801.51 Cr |
| Interest Expense | - | 3.85 Cr | 3.59 Cr | 5.86 Cr | 7.83 Cr |
| Pretax Income | - | 654.18 Cr | 502.95 Cr | 680.24 Cr | 727.56 Cr |
| Tax Provision | - | 151.97 Cr | 133.20 Cr | 173.79 Cr | 184.59 Cr |
| Net Income | - | 502.21 Cr | 369.54 Cr | 505.50 Cr | 542.96 Cr |
| Diluted EPS | 8.49 | 10.06 | 7.40 | 10.13 | - |
Compounded Sales Growth
| 5 Years: | -2.31% |
| 1 Year: | 0.60% |
Compounded Profit Growth
| 5 Years: | 2.64% |
| 1 Year: | 11.50% |
Stock Price Performance
| 1 Year: | -0.06% |
| 6 Months: | +12.73% |
| 3 Months: | +21.62% |
| 1 Month: | +14.93% |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Total Assets | - | 3,368.71 Cr | 3,313.27 Cr | 3,964.43 Cr | 4,474.19 Cr |
| Current Assets | - | 2,787.55 Cr | 2,672.86 Cr | 3,020.30 Cr | 3,340.15 Cr |
| Cash & Equivalents | - | 46.89 Cr | 46.64 Cr | 38.23 Cr | 68.92 Cr |
| Inventory | - | 888.70 Cr | 610.41 Cr | 703.66 Cr | 766.12 Cr |
| Receivables | - | 946.06 Cr | 715.91 Cr | 783.37 Cr | 735.61 Cr |
| Total Liabilities | - | 986.93 Cr | 868.73 Cr | 1,059.35 Cr | 1,080.41 Cr |
| Current Liabilities | - | 933.00 Cr | 800.70 Cr | 965.18 Cr | 969.81 Cr |
| Long Term Debt | - | - | - | - | 1.33 Cr |
| Total Debt | - | 33.97 Cr | 30.25 Cr | 51.89 Cr | 63.30 Cr |
| Total Equity | - | 2,381.78 Cr | 2,441.57 Cr | 2,901.14 Cr | 3,389.67 Cr |
| Shares Outstanding | - | 49.91 Cr | 49.91 Cr | 49.91 Cr | 49.91 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | 221.78 Cr | 389.38 Cr | 757.17 Cr | 451.50 Cr | 445.51 Cr |
| Investing Cash Flow | -290.20 Cr | -327.19 Cr | -420.38 Cr | -391.99 Cr | -331.95 Cr |
| Financing Cash Flow | -62.64 Cr | -72.55 Cr | -337.05 Cr | -67.92 Cr | -82.88 Cr |
| Capital Expenditure | -113.52 Cr | -119.88 Cr | -63.74 Cr | -29.45 Cr | -44.22 Cr |
| Free Cash Flow | 108.26 Cr | 269.50 Cr | 693.43 Cr | 422.05 Cr | 401.30 Cr |
| Net Change in Cash | -131.06 Cr | -10.36 Cr | -25.50 L | -8.40 Cr | 30.68 Cr |
Ratios (Annual)
Figures in %.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Margin % | - | 34.2% | 36.2% | 41.0% | 42.0% |
| Operating Margin % | - | 17.7% | 15.2% | 18.0% | 18.7% |
| Net Margin % | - | 14.5% | 13.1% | 16.1% | 16.8% |
| ROE % | - | 21.1% | 15.1% | 17.4% | 16.0% |
| ROCE % | - | 25.3% | 17.0% | 18.9% | 17.3% |
Shareholding Pattern
Insiders
75.48%
Institutions
8.80%
Public Float
35.87%
Analyst View
Loading analyst coverage…
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for SUMICHEM
No recent headlines available.